# HEMGENIX

NDC: 0053-0100
Generic name: etranacogene dezaparvovec
Labeler / Manufacturer: CSL Behring
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20221122

FDA application: BLA125772

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0053-0100"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0053-0100
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=35b2db65-4c6c-4173-ab56-b2bca69193bd